Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McNeil's Nicotrol is first nicotine patch switched by FDA; will be in stores by July 18.

This article was originally published in The Tan Sheet

Executive Summary

NICOTROL NICOTINE PATCH WILL BE ON SHELVES BY JULY 18, following July 3 approval from FDA for OTC marketing, McNeil Consumer announced. The transdermal patch will be available in a 15 mg strength to be used daily for six weeks. Nicotrol was unanimously recommended as safe and effective for over-the-counter use as a smoking cessation aid by FDA's Nonprescription Drugs Advisory Committee and members of the Drug Abuse Advisory Committee on April 19 ("The Tan Sheet" April 22, p. 1).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel